Cancer Medicine Journal Issues Research Articles in Part 2 of March 2020 Edition
March 11, 2020
March 11, 2020
MEDFORD, Massachusetts, March 11 -- Cancer Medicine, a peer-reviewed journal that says it features research from biomedical researchers across the cancer sciences, published research articles, including the following topics, in Part 2 of its March 2020 edition:
* Daratumumab prevents programmed death ligand-1 expression on antigen-presenting cells in de novo multiple myeloma
* Detection of plasma EGFR mutations for personalized treatment of lung cancer patients without . . .
* Daratumumab prevents programmed death ligand-1 expression on antigen-presenting cells in de novo multiple myeloma
* Detection of plasma EGFR mutations for personalized treatment of lung cancer patients without . . .